Abstract:Introduction: Our laboratory has reported that pancreatic and duodenal homeobox-1 (PDX-1), a homeodomain-containing transcription factor that regulates insulin expression in the adult islet, is an oncogene and is markedly overexpressed in pancreatic cancer, neuroendocrine tumors and pancreatitis. As the mechanism of PDX-1 overexpression is unknown, we hypothesize that alterations in the ubiquitin pathway resulting in decreased PDX-1 protein degradation is in part responsible. The purpose of this study is to determine whether PDX-1 stability is regulated through a mechanism of phosphorylation-dependent inhibition of PDX-1 ubiquitination. Methods: The p38-PDX-1 interaction was examined by performing Immunoprecipitation/Western blotting. Transient transfection was performed using Lipofectamine 2000. In vitro immunocomplex kinase assays were performed to determine if p38 has kinase activity toward PDX-1. Site-directed mutagenesis was applied to mutate Serine 269 residue of PDX-1 into alanine. The half-life of PDX-1 was measured by using cycloheximide. PDX-1 ubiquitination was measured by immunoprecipitating PDX-1, followed by Western blotting of ubiquitin. Results: 1. Immunoprecipitation/Western blot analysis showed that p38 MAP kinase physically associated with PDX-1 in a transient transfection system of HEK293 cells; 2. p38 MAP kinase showed kinase activity toward PDX-1 as evidenced by its ability to phosphorylate PDX-1 in vitro; 3. Mutation of serine 269 into alanine led to loss of PDX-1 phosphorylation by p38, suggesting that Ser 269 is a potential p38-regulated phosphorylation site within PDX-1; 4. The expression level of PDX-1 S269A was significantly lower than that of WT PDX-1; 5. The half-life of PDX-1 S269A was significantly shorter than that of WT PDX-1, indicating the role of Ser 269 phosphorylation in stabilizing PDX-1; and 6. The mutated PDX-1 S269A had higher level of ubiquitination than that of WT PDX-1, suggesting that p38 stabilizes PDX-1 through a mechanism of phosphorylation-dependent inhibition of PDX-1 ubiquitination. Conclusion: This study suggests that cellular expression level of PDX-1 is controlled in part by the ubiquitin pathway. Specifically, the data suggest that p38 MAP kinase phosphorylation of Ser 269 of PDX-1 leads to the inhibition of PDX-1 ubiquitination with stabilization of PDX-1. This study provides a potential new direction for future PDX-1-based tumor therapy by providing novel therapeutic targets.

Dual-specificity Phosphatase DUSP1 Protects Overactivation of Hypoxia-Inducible Factor 1 Through Inactivating ERK MAPK.

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy.

Dusp1 is Controlled by P53 During the Cellular Response to Oxidative Stress

Biphasic Regulation of Mitogen-Activated Protein Kinase Phosphatase 3 in Hypoxic Colon Cancer Cells

DUSP1 Alleviates Cardiac Ischemia/reperfusion Injury by Suppressing the Mff-required Mitochondrial Fission and Bnip3-related Mitophagy Via the JNK Pathways

DUSP1 recuses diabetic nephropathy via repressing JNK-Mff-mitochondrial fission pathways

Mitogen-Activated Protein Kinase Phosphatase-1: A Critical Phosphatase Manipulating Mitogen-Activated Protein Kinase Signaling In Cardiovascular Disease

Signal Pathway of Hypoxia-Inducible Factor-1α Phosphorylation and its Interaction with von Hippel-Lindau Tumor Suppressor Protein During Ischemia in MiaPaCa-2 Pancreatic Cancer Cells

A Molecular Link Between E2F-1 and the MAPK Cascade.

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Phosphorylation-Dependent Stabilization of Pancreatic and Duodenal Homeobox-1 (PDX-1)

Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells

Growth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression

Combinatorial regulation by ERK1/2 and CK1δ protein kinases leads to HIF-1α association with microtubules and facilitates its symmetrical distribution during mitosis

CIC is a Mediator of the ERK1/2-DUSP6 Negative Feedback Loop.

Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway

Modeling the Regulation of P53 Activation by HIF‐1 Upon Hypoxia

DUSP6 SUMOylation Protects Cells from Oxidative Damage Via Direct Regulation of Drp1 Dephosphorylation

Dual-specificity Phosphatase 26 Protects Against Kidney Injury Caused by Ischaemia-Reperfusion Through Restraint of TAK1-JNK/p38-mediated Apoptosis and Inflammation of Renal Tubular Epithelial Cells

USP15 inhibits hypoxia‐induced IL‐6 signaling by deubiquitinating and stabilizing MeCP2

ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1